catalyst · primary record
FDA Press Releases
News catalyst · 2026-10-30 · regulatory-approval, designation
| Company | FDA Press Releases |
|---|---|
| Ticker | Not stated |
| Impact | medium |
| Detail | FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis |
| Source | FDA Press Releases |
Provenance
- Source: FDA Press Releases
- Fetched at: 2026-10-31T01:01:07.647Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: FDA Press Releases::2026-10-30:FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.